Objective Testing for ADHD: Latest Tests and Benefits

Jennie Byrne, MD, PhD, a psychiatrist and neuroscientist, discussed the role of objective testing in the assessment and management of adult attention-deficit/hyperactivity disorder (ADHD). Byrne emphasized that objective measures provided a treat-to-target metric analogous to blood pressure monitoring in primary care. In her practice, she incorporated computerized assessments, such as QbCheck, to evaluate reaction time, reaction time variability, and motor activity, and she repeated testing after medication initiation to assess treatment response.¹ She stressed that such tools complemented, rather than replaced, clinical judgment.

Byrne described ADHD assessment as inherently complex, citing evolving diagnostic definitions, high rates of comorbidity, and pervasive misinformation.² She conceptualized ADHD as a neuroanatomic brain variant affecting approximately 5% of the population, rather than a condition caused by screen exposure, as it has been characterized by some. She noted that adult ADHD frequently cooccurred with depression, anxiety, substance use, sleep disturbance, and medical conditions, requiring careful diagnostic disentanglement.

Byrne outlined a 3-pronged diagnostic approach consisting of a comprehensive clinical interview, objective computerized testing, and collateralized rating scales reflecting lived experience. She cautioned against overreliance on any single data point and drew parallels to medical decision-making that integrated history, examination, and longitudinal data.

She further critiqued the prevailing “disorder” framing of ADHD, arguing that deficit-based language in research and media contributed to stigma and shame. Byrne reviewed the historical shift toward diagnostic categorization in psychiatry as a corrective to psychoanalytic non-specificity, while suggesting that contemporary practice could evolve toward a more strengths-informed, neuroscience-based narrative.

Finally, Byrne addressed stigma related to stimulant prescribing, Drug Enforcement Administration oversight, and telehealth. She clarified that not all patients require medication, that nonstimulant options exist, and that telehealth represents a modality of communication rather than a determinant of clinical quality.

Dr Byrne is a practicing psychiatrist and neuroscientist, as well as an advisor for healthcare innovators.

References

1. QbCheck. Accessed February 18, 2026. https://www.qbtech.com/adhd-tests/qbcheck/

2. ADHD and co-occurring conditions. Children and Adults with Attention-Deficit/Hyperactivity Disorder. Accessed February 18, 2026. https://chadd.org/about-adhd/co-occuring-conditions/